36519-31-0CC(C)(C)NCC(O)c1ccc(O)c(CO)c1.CC(C)(C)NCC(O)c1ccc(O)c(CO)c1.O=S(=O)(O)OBNPSSFBOAGDEEL-UHFFFAOYSA-NAlbuterol sulfate is an ethanolamine sulfate salt. It is functionally related to an albuterol.
36519-31-0、51022-70-9、67713-16-0DTXSID10881180CHEMBL1441059CHEBI:2550Breast Feeding; Lactation; Milk, Human; Anti-Asthmatic Agents; Bronchodilator Agents; Beta Adrenergic Agonists
FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
Hexotonal
UN0393
Div 1.1 Explosives (with a mass explosion hazard) (49 eCFR § 173.50)
Torpex
A Commercial Grade
5000
A Commercial Grade
400
Explosive chemical that can be released at a facility.
Salbutamol is a beta(2)-adrenergic agonist and thus it stimulates beta(2)-adrenergic receptors. Binding of albuterol to beta(2)-receptors in the lungs results in relaxation of bronchial smooth muscles. It is believed that salbutamol increases cAMP production by activating adenylate cyclase, and the actions of salbutamol are mediated by cAMP. Increased intracellular cyclic AMP increases the activity of cAMP-dependent protein kinase A, which inhibits the phosphorylation of myosin and lowers intracellular calcium concentrations. A lowered intracellular calcium concentration leads to a smooth muscle relaxation and bronchodilation. In addition to bronchodilation, salbutamol inhibits the release of bronchoconstricting agents from mast cells, inhibits microvascular leakage, and enhances mucociliary clearance.
Hydrolyzed by esterases in tissue and blood to the active compound colterol. The drug is also conjugatively metabolized to salbutamol 4'-O-sulfate. Route of Elimination: Approximately 72% of the inhaled dose is excreted in the urine within 24 hours, 28% as unchanged drug and 44% as metabolite. Half Life: 1.6 hours
ALBUTEROL SULFATE
Adrenergic beta2-Agonists [MoA]; beta2-Adrenergic Agonist [EPC]
Agents that cause an increase in the expansion of a bronchus or bronchial tubes.
Drugs that prevent preterm labor and immature birth by suppressing uterine contractions (TOCOLYSIS). Agents used to delay premature uterine activity include magnesium sulfate, beta-mimetics, oxytocin antagonists, calcium channel inhibitors, and adrenergic beta-receptor agonists. The use of intravenous alcohol as a tocolytic is now obsolete.
Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS.
現在のフィルター条件では反応記録がありません。
読み込み中…
Torpex
A Commercial Grade
5000
A Commercial Grade
400
Explosive chemical that can be released at a facility.